Bluejay Diagnostics (BJDX) Other Non-Current Assets (2021 - 2026)
Bluejay Diagnostics (BJDX) posted Other Non-Current Assets of $10832.0 for Q1 2026, up 37.03% sequentially from $7905.0 in Q4 2025, and down 68.54% YoY from $34435.0 in Q1 2025.
Bluejay Diagnostics (BJDX) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Other Non-Current Assets for 6 years, with the latest figure at $10832.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 68.54% year-over-year to $10832.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10832.0 (down 68.54% YoY) and the FY2025 annual result came in at $7905.0, down 77.58% from the prior year.
- Other Non-Current Assets advanced to $10832.0 in Q1 2026 per BJDX's latest filing, from $7905.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $35257.0 in Q4 2024 and troughed at $7905.0 in Q4 2025.
- A 5-year average of $25895.5 and a median of $28663.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 67.52% in 2022, then tumbled 77.58% in 2025.
- Over 5 years, Other Non-Current Assets stood at $35211.0 in 2022, then declined by 18.6% to $28663.0 in 2023, then gained by 23.01% to $35257.0 in 2024, then sank by 77.58% to $7905.0 in 2025, then soared by 37.03% to $10832.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $10832.0, $7905.0, and $8727.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Bluejay Diagnostics | 1.93 Mn | 1.93 Mn | - | 6,261.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,261.00 |
| Mar 31, 2026 | 10,832.00 |
| Dec 31, 2025 | 7,905.00 |
| Sep 30, 2025 | 8,727.00 |
| Jun 30, 2025 | 22,164.00 |
| Mar 31, 2025 | 34,435.00 |
| Dec 31, 2024 | 35,257.00 |
| Sep 30, 2024 | 23,598.00 |
| Jun 30, 2024 | 24,407.00 |
| Mar 31, 2024 | 25,215.00 |
| Dec 31, 2023 | 28,663.00 |
| Sep 30, 2023 | 29,907.00 |
| Jun 30, 2023 | 31,675.00 |
| Mar 31, 2023 | 33,443.00 |
| Dec 31, 2022 | 35,211.00 |
| Sep 30, 2022 | 33,479.00 |
| Jun 30, 2022 | 35,075.00 |
| Mar 31, 2022 | 20,231.00 |
| Dec 31, 2021 | 21,019.00 |